On July 17, BeiGene fell 3.04% in regular trading, trading at HKD 185.5/share, with turnover of HKD 313 million.

Within the Biotechnology sector where BeiGene belongs, stocks were broadly under pressure. Among individual stocks, AKESO down 12.52%, 3SBIO down 12.17%, REMEGEN down 10.35%, SKB BIO down 6.83%, INNOVENT BIO down 6.05%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)